Subscribe free to our newsletters via your
. Space Travel News .




EPIDEMICS
A mighty fighting flu breakthrough
by Staff Writers
Canberra, Australia (SPX) Feb 26, 2013


Dr Jenny McKimm-Breschkin showing drug killing viruses in cell culture.

The new drug has been proven to be effective in preventing the spread of different strains of influenza in laboratory models - including resistant strains of the virus.

The breakthrough is the result of a global collaboration between scientists from CSIRO, the University of British Columbia and the University of Bath.

In order to infect cells, flu viruses bind onto sugars on the cell surface. To be able to spread they need to remove these sugars. The new drug works by preventing the virus from removing sugars and blocking the virus from infecting more cells. It is hoped the drug will also be effective against future strains of the virus.

According to the World Health Organisation, influenza kills approximately 500,000 people each year, with up to 2500 of those deaths occurring in Australia[1]. Costs to the Australian health care system are estimated to be more than A$85M, with more than 1.5 million work days lost annually.

CSIRO scientist Dr Jenny McKimm-Breschkin, a researcher in the team that developed the first flu drug Relenza, said that understanding exactly how flu viruses become resistant to drugs has helped them to design a better flu drug.

"CSIRO researchers have shown that flu viruses continually mutate and some have become resistant to available treatments," Dr Jenny McKimm-Breschkin said.

"The new drug is effective against these resistant strains. As the site where the drug binds is found in all flu strains, the new drug is expected to be effective even against future flu strains.

"With millions of poultry currently infected with 'bird flu' globally, there are still concerns about its adaptation and potential to spread among humans, causing the next pandemic," she added.

Professor Steve Withers, University of British Columbia, has led the research team for the past seven years and said that although further studies are required to determine efficacy against a broader range of flu strains, the findings are extremely positive.

"Despite recent improvements in vaccine production, when a new strain of flu emerges it can take several months before vaccines are available to the public," Professor Steve Withers said.

"This antiviral drug would play an important role as the first line of defence in modulating disease severity and in controlling a pandemic while vaccines are prepared," he added.

Details of the research have been published in a paper titled: 'Mechanism-based Covalent Neuraminidase Inhibitors with Broad Spectrum Influenza Antiviral Activity'. Researchers estimate it will take up to seven years before the drug is released.

.


Related Links
CSIRO
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle




Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News





EPIDEMICS
Using transportation data to predict pandemics
Evanston IL (SPX) Feb 26, 2013
In a world of increasing global connections, predicting the spread of infectious diseases is more complicated than ever. Pandemics no longer follow the patterns they did centuries ago, when diseases swept through populations town by town; instead, they spread quickly and seemingly at random, spurred by the interactions of 3 billion air travelers per year. A computational model developed by ... read more


EPIDEMICS
SpaceX 2 Launch Set for March 1

NASA Releases Glory Taurus XL Launch Failure Report Summary

India's 102nd space mission lifts off successfully

Countdown begins for Indo-French satellite launch

EPIDEMICS
Mars rover ingests rock powder for tests

Opportunity Is On A Rock Hunt

Big Nickel Rock Target Ahead

NASA Rover Confirms First Drilled Mars Rock Sample

EPIDEMICS
Water On The Moon: It's Been There All Along

Building a lunar base with 3D printing

US, Europe team up for moon fly-by

Russia to Launch Lunar Mission in 2015

EPIDEMICS
'Vulcan' wins Pluto moon name vote

Public to vote on names for Pluto moons

The PI's Perspective: The Seven-Year Itch

New Horizons Gets a New Year's Workout

EPIDEMICS
NASA's Kepler Mission Discovers Tiny Planet System

Kepler helps astronomers find tiny exo planet

Searching for a Pale Blue SPHERE in the Universe

Earth-like planets are right next door

EPIDEMICS
NASA Partner Orbital Tests Rocket, Newest US Launch Pad

NASA Seeks Big Ideas for Small In-Space Propulsion Systems

Start Me Up!

NASA Awards Final Space Launch System Advanced Booster Contract

EPIDEMICS
Welcome Aboard Shenzhou 10

Reshuffle for Tiangong

China to launch 20 spacecrafts in 2013

Mr Xi in Space

EPIDEMICS
Asteroid impact mission targets Didymos

Apophis Risk Assessment Updated

Discovering the birth of an asteroid trail

The NASA Comet ISON Observing Campaign




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement